14-3-3 Proteins and protein phosphatases are not reduced in tau-deficient mice

NeuroReport

Volumn 18, Issue 10, 2007, Pages 1049-1052

  Fujio, Katsunori ^a   Sato, Mahito ^b   Uemura, Takefumi ^a   Sato, Takashi ^a   Sato Harada, Reiko ^a   Harada, Akihiro ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

14 3 3; Alzheimer's disease; Glycogen synthase kinase 3 ; Knockout mice; Microtubule associated protein; Protein phosphatase; Tau; Tauopathies

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE; PROTEIN 14 3 3; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; KNOCKOUT MOUSE; MICROTUBULE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; WESTERN BLOTTING; WILD TYPE;

14-3-3 PROTEINS; ANIMALS; BRAIN; BRAIN CHEMISTRY; MICE; MICE, KNOCKOUT; PHOSPHOPROTEIN PHOSPHATASE; TAU PROTEINS;

EID: 34250197901     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32818b2a0b     Document Type: Article

References (22)

1. Hirokawa N. Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr Opin Cell Biol 1994; 6:74-81.
2. Garcia ML, Cleveland DW. Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. Curr Opin Cell Biol 2001; 13:41-48.
3. Theurkauf WE, Vallee RB. Molecular characterization of the cAMP-dependent protein kinase bound to microtubule-associated protein 2. J Biol Chem 1982; 257:3284-3290.
4. Price NE, Mumby MC. Brain protein serine/threonine phosphatases. Curr Opin Neurobiol 1999; 9:336-342.
5. Harada A, Teng J, Takei Y, Oguchi K, Hirokawa N. MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. J Cell Biol 2002; 158:541-549.
6. Iriuchijima N, Sato-Harada R, Takano M, Fujio K, Sato T, Goto F, et al. Reduced expression of kinase-associated phosphatase in cortical dendrites of MAP2-deficient mice. Biochem Biophys Res Commun 2005; 338:1216-1221.
7. Berg D, Holzmann C, Riess O. 14-3-3 proteins in the nervous system. Nat Rev Neurosci 2003; 4:752-762.
8. Hashiguchi M, Sobue K, Paudel HK. 14-3-3zeta is an effector of tau protein phosphorylation. J Biol Chem 2000; 275:25247-25254.
9. Agarwal-Mawal A, Qureshi HY, Cafferty PW, Yuan Z, Han D, Lin R, et al. 14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex. J Biol Chem 2003; 278:12722-12728.
10. Yuan Z, Agarwal-Mawal A, Paudel HK. 14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain. J Biol Chem 2004; 279:26105-26114.
11. Hernandez F, Cuadros R, Avila J. Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers. Neurosci Lett 2004; 357: 143-146.
12. Morishima-Kawashima M, Ihara Y. Alzheimer's disease: beta-amyloid protein and tau. J Neurosci Res 2002; 70:392-401.
13. Liao H, Li Y, Brautigan DL, Gundersen GG. Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein tau. J Biol Chem 1998; 273:21901-21908.
14. Sontag E, Nunbhakdi-Craig V, Lee G, Brandt R, Kamibayashi C, Kuret J, et al. Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. J Biol Chem 1999; 274:25490-25498.
15. Goedert M, Satumtira S, Jakes R, Smith MJ, Kamibayashi C, White CL III, et al. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations. J Neurochem 2000; 75:2155-2162.
16. Billingsley ML, Kincaid RL. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 1997; 323:577-591.
17. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, et al. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 1994; 369:488-491.
18. Sato T, Sato-Harada R, Takano M, Kato S, Saburi S, Harada A. Localization of cAMP-dependent protein kinase in the actin and microtubule cytoskeletons in mouse hippocampal neurons. Neurosci Lett 2002; 325:83-86.
19. Matthews TA, Johnson GV. 14-3-3Zeta does not increase GSK3beta-mediated tau phosphorylation in cell culture models. Neurosci Lett 2005; 384:211-216.
20. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393:702-705.
21. Sergeant N, Delacourte A, Buee L. Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 2005; 1739:179-197.
22. Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 2005; 1739:198-210.